Insider Transactions in Q2 2024 at Ngm Biopharmaceuticals Inc (NGM)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 05
2024
|
Column Group Gp, LP > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
1,000
+50.0%
|
-
|
|
Apr 05
2024
|
Column Group Gp, LP > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
10,640,080
-100.0%
|
-
|
|
Apr 05
2024
|
Column Group Gp, LP > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Direct |
11,103,333
-100.0%
|
-
|
|
Apr 05
2024
|
Tcg Opportunity Iii Gp, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
1,000
+50.0%
|
-
|
|
Apr 05
2024
|
Tcg Opportunity Iii Gp, LLC > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
10,640,080
-100.0%
|
-
|
|
Apr 05
2024
|
Tcg Opportunity Iii Gp, LLC > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Direct |
11,103,333
-100.0%
|
-
|
|
Apr 05
2024
|
David V Goeddel Director |
BUY
Other acquisition or disposition
|
Indirect |
1,000
+50.0%
|
-
|
|
Apr 05
2024
|
David V Goeddel Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
21,874,413
-100.0%
|
-
|
|
Apr 05
2024
|
David V Goeddel Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
134,180
-100.0%
|
-
|
|
Apr 05
2024
|
Column Group L P Director |
BUY
Other acquisition or disposition
|
Indirect |
1,000
+50.0%
|
-
|
|
Apr 05
2024
|
Column Group L P Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
10,640,080
-100.0%
|
-
|
|
Apr 05
2024
|
Column Group L P Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
11,103,333
-100.0%
|
-
|
|
Apr 05
2024
|
David J Woodhouse Chief Executive Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
97,654
-100.0%
|
-
|
|
Apr 05
2024
|
David J Woodhouse Chief Executive Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
23,993
-100.0%
|
-
|
|
Apr 05
2024
|
Jean Frederic Viret Chief Financial Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
3,038
-100.0%
|
-
|
|
Apr 05
2024
|
William Jl Rieflin |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
2,769,168
-100.0%
|
-
|
|
Apr 05
2024
|
William Jl Rieflin |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
5,172
-100.0%
|
-
|
|
Apr 05
2024
|
Valerie L Pierce |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
26,458
-100.0%
|
-
|
|
Apr 05
2024
|
Suzanne Sawochka Hooper |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
7,000
-100.0%
|
-
|
|
Apr 05
2024
|
Irene Perlich Principal Accounting Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
6,284
-100.0%
|
-
|
|
Apr 05
2024
|
Hsiao D Lieu Chief Medical Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
19,349
-100.0%
|
-
|